Premium
Beta‐radiation for coronary in‐stent restenosis
Author(s) -
Latchem Donald R.,
Urban Philip,
Goy JeanJacques,
De Benedetti Edoardo,
Pica Alessia,
Coucke Philippe,
Eeckhout Eric
Publication year - 2000
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/1522-726x(200012)51:4<422::aid-ccd10>3.0.co;2-a
Subject(s) - medicine , restenosis , stenosis , angioplasty , cardiology , stent , myocardial infarction , radiology , angiography
To determine the feasibility and safety of an intracoronary beta‐radiation device in preventing the recurrence of in‐stent restenosis (ISR) after successful angioplasty, we studied 37 patients treated with beta‐radiation (30‐mm strontium‐90 source) after angioplasty. The mean reference diameter was 2.9 ± 0.5 mm, and 62% of lesions were diffuse, including four total occlusions. Beta‐radiation was successfully delivered in 36 of 37 (97%) cases. Over the course of 7.1 ± 4.5 mo follow‐up, there were no myocardial infarctions and three deaths: one from preexisting malignancy, one from progressive cardiac failure, and one from sudden cardiac death. Target vessel revascularization (TVR) was performed in seven of 36 (19%) patients. Thirty patients underwent angiography at 6 mo; three (10%) experienced restenosis (diameter stenosis > 50%) at the target site, four (13%) had edge stenoses, and two (7%) had late (> 1 mo) thrombotic occlusions. Beta‐radiation for ISR is associated with encouragingly low rates of target lesion restenosis and TVR. Further improvements are needed to solve the limitations of the edge effect and late occlusion. Cathet. Cardiovasc. Intervent. 51:422–429, 2000. © 2000 Wiley‐Liss, Inc.